Skip header and navigation

1 records – page 1 of 1.

Feasibility and preliminary efficacy of progressive resistance exercise training in lung cancer survivors.

https://arctichealth.org/en/permalink/ahliterature133330
Source
Lung Cancer. 2012 Jan;75(1):126-32
Publication Type
Article
Date
Jan-2012
Author
Carolyn J Peddle-McIntyre
Gordon Bell
David Fenton
Linda McCargar
Kerry S Courneya
Author Affiliation
Faculty of Physical Education and Recreation, University of Alberta, E-488 Van Vliet Center, Edmonton, Alberta, Canada.
Source
Lung Cancer. 2012 Jan;75(1):126-32
Date
Jan-2012
Language
English
Publication Type
Article
Keywords
Aged
Aged, 80 and over
Canada
Carcinoma, Non-Small-Cell Lung - physiopathology - rehabilitation
Disease Progression
Exercise
Exercise Therapy - methods
Fatigue - therapy
Feasibility Studies
Female
Follow-Up Studies
Humans
Lost to Follow-Up
Lung Neoplasms - physiopathology - rehabilitation
Male
Middle Aged
Muscle strength
Quality of Life
Resistance Training
Survivors
Treatment Outcome
Abstract
Lung cancer survivors exhibit poor functional capacity, physical functioning, and quality of life (QoL). Here, we report the feasibility and preliminary efficacy of a progressive resistance exercise training (PRET) intervention in post-treatment lung cancer survivors. Seventeen post-treatment lung cancer survivors (10 female), with a mean age of 67 (range 50-85), mean BMI of 25, and diagnosed with non-small cell lung cancer (94%) were recruited in Edmonton, Canada between August 2009 and August 2010 to undergo PRET. The primary outcomes focused on feasibility including eligibility and recruitment rate, loss to follow-up, measurement completion, exercise adherence, and program evaluation. Secondary outcomes addressed preliminary efficacy and included changes in muscular strength (1 repetition maximum), muscular endurance (repetitions at 70% of 1 repetition maximum), body composition (DXA scan), physical functioning (6-minute-walk-test, up-and-go, sit-to-stand, arm curls), and patient-reported outcomes including QoL (SF-36, FACT-L), fatigue (FACT-F), dyspnea (MRCD), and patient-rated function (LLFI). Forty of 389 lung cancer survivors were eligible (10%) and 17 of the 40 (43%) were recruited. Over 80% of participants were able to complete all testing; two participants were lost to follow-up, and the median adherence rate was 96% (range: 25-100%). Ratings of testing burden were low (i.e., less than two out of seven for all items), and trial evaluation was high (i.e., greater than six out of seven for all measures). Paired t-tests showed significant increases in muscular strength (p
PubMed ID
21715041 View in PubMed
Less detail